BioXcel Therapeutics, Inc. (BTAI)
NASDAQ · Healthcare
BioXcel Therapeutics, Inc. Price to Book Ratio 2018–2026
Price to book (P/B) ratio for BioXcel Therapeutics, Inc. (BTAI): market cap divided by shareholder equity. As of September 30, 2023 it is 15.43.
From: 03/31/2018To: 03/31/2026
Stock Price
Book Value
Price to Book
BioXcel Therapeutics, Inc. Price to Book Ratio — FAQ
BioXcel Therapeutics, Inc. (BTAI) price to book ratio over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BTAI's price to book ratio history?
The chart and table above show BioXcel Therapeutics, Inc.'s price to book ratio by year and by quarter, including the growth rate.